Alira Health

Alira Health

HTAi 2024 Annual Meeting

June 15 - 19, 2024 | Seville, Spain

We are excited to announce that we will attend and speak the HTAi 2024 Annual Meeting, the arena where HTA stakeholders will have a dialogue on the development of tools and frameworks to assess healthcare technologies and related innovations. This year, the HTAi meeting will focus on the opportunities and challenges for growing valuable networks for HTAs and how collaboration can support the evaluation of innovative healthcare solutions.

Our speakers, Richard Charter and Jamie Erskine, will join the online panel “Value Assessment of Digital Technologies in Surgery: Results From an International Consensus Conference Study.” The study investigated the value of digital surgical technologies and potential HTA methods to best assess their value.

Health Technology Assessments (HTAs) of Robotic-Assisted Surgery (RAS) systems have proven difficult due to challenges with ethical data collection, the complexity of these products, and a lack of standardized methodology. As a result, these HTAs often come to very different conclusions or are unable to reach any firm conclusion. As the development of new RAS systems continues to grow, this situation is increasingly untenable.

To learn more about this topic, read the article “Best practice considerations on the assessment of robotic assisted surgical systems: results from an international consensus expert panel,” co-authored by our experts.

Published on:
May 23, 2024

Don’t Miss Our Panel!

Value Assessment of Digital Technologies in Surgery: Results From an International Consensus Conference Study

The panel will be available on-demand and in streaming on the virtual platform of the HTAi 2024 Annual Meeting. All attendees can watch it in streaming in the following slots during the Annual Meeting:

  • June 17 | 2.00 AM CEST
  • June 18 | 4.00 AM CEST
  • June 19 | 8.00 PM CEST

This panel session will explore the potential benefits of Digital Surgical Technologies, including reducing unwarranted variation in surgical practice, increasing access to surgery, and reducing health inequalities. It will also discuss the linkage between clinical and patient-related outcomes with objective performance indicators, and what this may mean for HTAs. Finally, the panel session will look at what other areas of digital technology may require similar HTA considerations.


  • Jamie Erskine, Senior Consultant, Market Access and Pricing, Alira Health
  • Richard Charter, Vice President , Medtech Market Access and Commercial Strategy EU and Asia, Alira Health
  • Matt Lien, Global Market Access and HTA Manager, Intuitive Surgical
  • Anastasia Chalkidou, Associate Director, MTEP and IP Programmes, NICE
  • Gretchen Purcell Jackson, Scientific Medical Officer for Digital, Intuitive Surgical
About Our Speakers
Richard Charter - Alira Health

Richard Charter

Vice President – Medtech Market Access and Commercial Strategy EU and Asia Pacific Richard Charter is Alira Health’s Medtech Market Access and Commercial Strategy Partner. Richard has over 20 years of experience in financial and health economics. Prior to joining Alira Health, he was the head of market access and pricing at a major medtech company, leading pricing, market access, and VBHC projects around Europe in multiple care delivery settings and therapeutic areas.
Richard is currently the co-chair of the HTAi Medical Device Interest Group, where he has worked extensively on HTA methods for RAS, and the ABHI Sustainability Working Group. His past chair roles include Medtech Europe Evidence and Payers Working Group and the ISPOR Medical Device Special Interest Group. Richard was also the industry advisor for the EU-funded Horizon 2020 COMED initiative on cost and outcomes measurement for medical devices.
Richard holds a Master of Science in healthcare management, economics, and policy from SDA Bocconi. He has also completed the Harvard Business School Intensive Course on Value-Based Healthcare.

Jamie Erskine

Senior Consultant, Market Access and Pricing  Jamie Erskine joined Alira Health in the Medtech Market Access and Commercial Strategy Team for Europe and Asia Pacific in September 2021. Jamie focuses on market access and health economics for medical devices, diagnostics, digital health technology, and AI in medicine. He holds a Master of Science in biomedical engineering from the University of Glasgow, specializing in medical imaging and medical devices, and completed his Master’s thesis in surgical robotics at the Delft University of Technology. He continues to work extensively in RAS and digital surgery, focusing on HTA and market access for these solutions. He has over six years of experience working in HTA and market access at both the national and local level in the UK and across Europe, leading independent assessments for NICE’s Medical Technologies Evaluation Programme and Diagnostics Assessment Programme. He has also worked extensively in evidence generation and clinical trials of medical devices and diagnostics. Jamie is the former Technical Officer of the HTAi Medical Devices Interest Group.

Related Health Technology Resources
RAS in Orthopedic Procedures RAS in Orthopedics Webinar Replay
strategic planning for RAS Challenges in Health Technology Assessments of RAS Systems
Best Practices Health Technology Assessment Robotics
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.